Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis
Clinical trial NCT02583048 · COMPLETED
Trial details
- NCT number
- NCT02583048
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-15
- Primary completion
- 2019-01-07
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.